期刊
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
卷 30, 期 2, 页码 179-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2010.02.001
关键词
Wiskott-Aldrich syndrome; Chimerism; X-linked thrombocytopenia; Hematopoietic cell transplantation; Immunodeficiency
资金
- Children's Hospital Boston
- Manton Foundation
- NIHP01-HL-059561-11A1 [P01-HL-059561-11A1]
The Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by a triad of diagnostic clinical elements: immunodeficiency, eczema, and hemorrhage caused by thrombocytopenia with small-sized platelets. Hematopoietic cell transplantation (HOT) can cure WAS, and is most often performed using myeloablative conditioning regimens. Our growing understanding of the biology of WASp has revealed cell-type specific functions that impact immune and hematopoietic outcome after HCT. Shortand long-term toxicities associated with HCT remain the main obstacle to safe and effective cure for every patient with WAS. Optimal management strategies for patients with milder forms of the disease (including X-linked thrombocytopenia) remain to be defined.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据